Novo Nordisk Stock Soars After Hours As FDA Greenlights Wegovy Pill For Weight Loss
Synopsis
The Danish drugmaker expects to launch the pill in the U.S. in January.
Shares of Novo Nordisk (NVO) jumped 10% after-hours on Monday after the U.S. Food and Drug Administration approved its Wegovy pill to reduce body weight and maintain weight reduction for longer term.
The Wegovy pill is now the first FDA-approved oral GLP-1 class drug for weight management.
The Danish drugmaker expects to launch the pill in the U.S. in January. The company is also looking forward to approval of the drug from other regulatory authorities including the European Medicines Agency.
Get updates to this developing story directly on Stocktwits.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.